Brilliance is an intellectual property platform built for the biotech ecosystem, helping innovators, IP owners, and investors unlock value from patents, license agreements, and royalty contracts.

For biotech companies, Brilliance helps you:

• Convert existing license agreement economics into upfront capital instead of waiting on back-ended payments
• Use Brilliance Connect to find collaboration partners, strategic partners, and potential licensees for your IP
• List and showcase licensable assets in our IP Repository to increase visibility and drive inbound interest

For VCs and other capital allocators, Brilliance enables access to investable royalty agreements and structured opportunities, including synthetic royalty structures tied to defined value events.